ArticleOPEN ACCESS

Correction: Oral esketamine for treatment-resistant depression: Rationale and design of a randomized controlled trial (BMC Psychiatry (2019) 19 (375) DOI: 10.1186/s12888-019-2359-1)

BMC Psychiatry
DOI: 10.1186/s12888-019-2398-7
2Citations
Citations of this article
27Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

After publication of our article [1] we were notified that Figure 1 was wrongly presented. The correct figure and corresponding title is presented below: (Figure presented).

Cite

CITATION STYLE

APA

Smith-Apeldoorn, S. Y., Veraart, J. K. E., Kamphuis, J., Van Asselt, A. D. I., Touw, D. J., Aan Het Rot, M., & Schoevers, R. A. (2020, January 8). Correction: Oral esketamine for treatment-resistant depression: Rationale and design of a randomized controlled trial (BMC Psychiatry (2019) 19 (375) DOI: 10.1186/s12888-019-2359-1). BMC Psychiatry. BioMed Central Ltd. https://doi.org/10.1186/s12888-019-2398-7

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free